0001493152-23-043745.txt : 20231205 0001493152-23-043745.hdr.sgml : 20231205 20231205172029 ACCESSION NUMBER: 0001493152-23-043745 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231201 FILED AS OF DATE: 20231205 DATE AS OF CHANGE: 20231205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bligh James CENTRAL INDEX KEY: 0001990748 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41245 FILM NUMBER: 231467637 MAIL ADDRESS: STREET 1: 38 OXBERRY AVENUE CITY: LONDON STATE: X0 ZIP: SW6 5SS ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CONDUIT PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0001896212 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 873272543 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4995 MURPHY CANYON ROAD, SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92123 BUSINESS PHONE: (760) 471 8536 MAIL ADDRESS: STREET 1: 4995 MURPHY CANYON ROAD, SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92123 FORMER COMPANY: FORMER CONFORMED NAME: Murphy Canyon Acquisition Corp. DATE OF NAME CHANGE: 20211130 4 1 ownership.xml X0508 4 2023-12-01 0 0001896212 CONDUIT PHARMACEUTICALS INC. CDT 0001990748 Bligh James 4995 MURPHY CANYON ROAD,SUITE 300 SAN DIEGO CA 92123 1 0 0 0 0 Stock Option (Right to Buy) 5.51 2023-12-01 4 A 0 223634 5.51 A 2033-11-30 Common Stock 223634 223634 D Represents Options to purchase common stock, granted under the Company's 2023 Stock Incentive Plan. The stock options were granted with a ten-year term and vest 25% on each of the first four anniversaries of the vesting commencement date, which is September 22, 2023. /s/ James Bligh 2023-12-05